Paper24281069
RETRACTED: Identification of Insulin-Like Growth Factor-I Receptor (IGF-IR) Gene Promoter-Binding Proteins in Estrogen Receptor (ER)-Positive and ER-Depleted Breast Cancer Cells.
Sarfstein R and 2 others. Cancers (Basel), 2010. Cited by 28 papers, by iCite. Retracted.
Cite this record
ConductScience Library. RETRACTED: Identification of Insulin-Like Growth Factor-I Receptor (IGF-IR) Gene Promoter-Binding Proteins in Estrogen Receptor (ER)-Positive and ER-Depleted Breast Cancer Cells. Papers, record 24281069. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/24281069
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- RETRACTED: Identification of Insulin-Like Growth Factor-I Receptor (IGF-IR) Gene Promoter-Binding Proteins in Estrogen Receptor (ER)-Positive and ER-Depleted Breast Cancer Cells.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Retracted by | 41186463 | RETRACTED: Sarfstein et al. Identification of Insulin-Like Growth Factor-I Receptor (IGF-IR) Gene Promoter-Binding Proteins in Estrogen Receptor (ER)-Positive and ER-Depleted Breast Cancer Cells. Cancers 2010, 2, 233-261. | https://conductscience.org/library/papers/41186463 |
Source PubMed
References60
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 8702614 | The IGF-I receptor gene promoter is a molecular target for the Ewing's sarcoma-Wilms' tumor 1 fusion protein. | J Biol Chem | 1996 | https://conductscience.org/library/papers/8702614 | PubMed |
| 2 | 17533376 | Oncogenic activation of the Met receptor tyrosine kinase fusion protein, Tpr-Met, involves exclusion from the endocytic degradative pathway. | Oncogene | 2007 | https://conductscience.org/library/papers/17533376 | PubMed |
| 3 | 11479214 | Re-expression of estrogen receptor alpha in estrogen receptor alpha-negative MCF-7 cells restores both estrogen and insulin-like growth factor-mediated signaling and growth. | Cancer Res | 2001 | https://conductscience.org/library/papers/11479214 | PubMed |
| 4 | 10749889 | Estrogen receptor alpha rapidly activates the IGF-1 receptor pathway. | J Biol Chem | 2000 | https://conductscience.org/library/papers/10749889 | PubMed |
| 5 | 16647191 | Transcriptional regulation of the insulin-like growth factor-I receptor gene in breast cancer. | Mol Cell Endocrinol | 2006 | https://conductscience.org/library/papers/16647191 | PubMed |
| 6 | 9242428 | Insulin-like growth factor-I receptor overexpression mediates cellular radioresistance and local breast cancer recurrence after lumpectomy and radiation. | Cancer Res | 1997 | https://conductscience.org/library/papers/9242428 | PubMed |
| 7 | 16087727 | The WT1 Wilms' tumor suppressor gene product interacts with estrogen receptor-alpha and regulates IGF-I receptor gene transcription in breast cancer cells. | J Mol Endocrinol | 2005 | https://conductscience.org/library/papers/16087727 | PubMed |
| 8 | 1448110 | Structural and functional analysis of the insulin-like growth factor I receptor gene promoter. | Mol Endocrinol | 1992 | https://conductscience.org/library/papers/1448110 | PubMed |
| 9 | 7491495 | Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase. | Science | 1995 | https://conductscience.org/library/papers/7491495 | PubMed |
| 10 | 7529598 | The insulin-like growth factor system as a target in breast cancer. | Breast Cancer Res Treat | 1994 | https://conductscience.org/library/papers/7529598 | PubMed |
| 11 | 8196606 | Effect of a null mutation of the insulin-like growth factor I receptor gene on growth and transformation of mouse embryo fibroblasts. | Mol Cell Biol | 1994 | https://conductscience.org/library/papers/8196606 | PubMed |
| 12 | 10188734 | Insulin receptor substrate 1 is a target for the pure antiestrogen ICI 182,780 in breast cancer cells. | Int J Cancer | 1999 | https://conductscience.org/library/papers/10188734 | PubMed |
| 13 | 15837762 | In vivo effects of the human type I insulin-like growth factor receptor antibody A12 on androgen-dependent and androgen-independent xenograft human prostate tumors. | Clin Cancer Res | 2005 | https://conductscience.org/library/papers/15837762 | PubMed |
| 14 | 10319328 | Enhancement of insulin-like growth factor signaling in human breast cancer: estrogen regulation of insulin receptor substrate-1 expression in vitro and in vivo. | Mol Endocrinol | 1999 | https://conductscience.org/library/papers/10319328 | PubMed |
| 15 | 2152773 | Insulin-like growth factor receptor expression and function in human breast cancer. | Cancer Res | 1990 | https://conductscience.org/library/papers/2152773 | PubMed |
| 16 | 12444079 | WT1-p53 interactions in insulin-like growth factor-I receptor gene regulation. | J Biol Chem | 2003 | https://conductscience.org/library/papers/12444079 | PubMed |
| 17 | 2174437 | Role of insulin-like growth factors and the type I insulin-like growth factor receptor in the estrogen-stimulated proliferation of human breast cancer cells. | J Biol Chem | 1990 | https://conductscience.org/library/papers/2174437 | PubMed |
| 18 | 8175666 | Transcriptional repression of the insulin-like growth factor I receptor (IGF-I-R) gene by the tumor suppressor WT1 involves binding to sequences both upstream and downstream of the IGF-I-R gene transcription start site. | J Biol Chem | 1994 | https://conductscience.org/library/papers/8175666 | PubMed |
| 19 | 12508239 | The IGFI receptor gene: a molecular target for disrupted transcription factors. | Genes Chromosomes Cancer | 2003 | https://conductscience.org/library/papers/12508239 | PubMed |
| 20 | 2553774 | Blockade of the type I somatomedin receptor inhibits growth of human breast cancer cells in athymic mice. | J Clin Invest | 1989 | https://conductscience.org/library/papers/2553774 | PubMed |
Cited by20
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 28 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41186463 | RETRACTED: Sarfstein et al. Identification of Insulin-Like Growth Factor-I Receptor (IGF-IR) Gene Promoter-Binding Proteins in Estrogen Receptor (ER)-Positive and ER-Depleted Breast Cancer Cells. Cancers 2010, 2, 233-261. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/41186463 | PubMed |
| 35320351 | The Role of ARID1A in the Nonestrogenic Modulation of IGF-1 Signaling. | Mol Cancer Res | 2022 | https://conductscience.org/library/papers/35320351 | PubMed |
| 34456716 | Antimetastatic Effects of Curcumin in Oral and Gastrointestinal Cancers. | Front Pharmacol | 2021 | https://conductscience.org/library/papers/34456716 | PubMed |
| 34417736 | 2021 update on thyroid-associated ophthalmopathy. | J Endocrinol Invest | 2022 | https://conductscience.org/library/papers/34417736 | PubMed |
| 33918477 | The Role of Nuclear Insulin and IGF1 Receptors in Metabolism and Cancer. | Biomolecules | 2021 | https://conductscience.org/library/papers/33918477 | PubMed |
| 32637033 | Tumor suppressor p53 regulates insulin receptor (INSR) gene expression via direct binding to the INSR promoter. | Oncotarget | 2020 | https://conductscience.org/library/papers/32637033 | PubMed |
| 31771180 | Differential Effects of Insulin and IGF1 Receptors on ERK and AKT Subcellular Distribution in Breast Cancer Cells. | Cells | 2019 | https://conductscience.org/library/papers/31771180 | PubMed |
| 31363162 | Nuclear KIT induces a NFKBIB-RELA-KIT autoregulatory loop in imatinib-resistant gastrointestinal stromal tumors. | Oncogene | 2019 | https://conductscience.org/library/papers/31363162 | PubMed |
| 30987250 | The Influence of Curcumin on the Downregulation of MYC, Insulin and IGF-1 Receptors: A possible Mechanism Underlying the Anti-Growth and Anti-Migration in Chemoresistant Colorectal Cancer Cells. | Medicina (Kaunas) | 2019 | https://conductscience.org/library/papers/30987250 | PubMed |
| 28815409 | Insulin-Like Growth Factor (IGF) Pathway Targeting in Cancer: Role of the IGF Axis and Opportunities for Future Combination Studies. | Target Oncol | 2017 | https://conductscience.org/library/papers/28815409 | PubMed |
| 27993167 | Prognostic value of cross-omics screening for kidney clear cell renal cancer survival. | Biol Direct | 2016 | https://conductscience.org/library/papers/27993167 | PubMed |
| 27446805 | Insulin-like Growth Factor 1 Signaling Axis Meets p53 Genome Protection Pathways. | Front Oncol | 2016 | https://conductscience.org/library/papers/27446805 | PubMed |
| 27405474 | Insulin-like growth factor-1 signaling in renal cell carcinoma. | BMC Cancer | 2016 | https://conductscience.org/library/papers/27405474 | PubMed |
| 27285981 | TMPRSS2-ERG fusion protein regulates insulin-like growth factor-1 receptor (IGF1R) gene expression in prostate cancer: involvement of transcription factor Sp1. | Oncotarget | 2016 | https://conductscience.org/library/papers/27285981 | PubMed |
| 25964777 | Role of IGF1R in Breast Cancer Subtypes, Stemness, and Lineage Differentiation. | Front Endocrinol (Lausanne) | 2015 | https://conductscience.org/library/papers/25964777 | PubMed |
| 25743390 | The role of the insulin-like growth factor-1 system in breast cancer. | Mol Cancer | 2015 | https://conductscience.org/library/papers/25743390 | PubMed |
| 24550888 | The emerging role of insulin and insulin-like growth factor signaling in cancer stem cells. | Front Endocrinol (Lausanne) | 2014 | https://conductscience.org/library/papers/24550888 | PubMed |
| 23620761 | Metformin downregulates the insulin/IGF-I signaling pathway and inhibits different uterine serous carcinoma (USC) cells proliferation and migration in p53-dependent or -independent manners. | PLoS One | 2013 | https://conductscience.org/library/papers/23620761 | PubMed |
| 22128190 | Insulin-like growth factor-I receptor (IGF-IR) translocates to nucleus and autoregulates IGF-IR gene expression in breast cancer cells. | J Biol Chem | 2012 | https://conductscience.org/library/papers/22128190 | PubMed |
| 21963847 | Tumor suppressors govern insulin-like growth factor signaling pathways: implications in metabolism and cancer. | Oncogene | 2012 | https://conductscience.org/library/papers/21963847 | PubMed |
Genes88
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/24281069
GET https://conductscience.org/api/papers/v1/24281069/references?page=2